Cardiovascular outcomes in de novo Kidney transplant recipients receiving everolimus and reduced calcineurin inhibitor or standard triple therapy: 24-month post hoc analysis from TRANSFORM study - Sommerer, Claudia; Legendre, Christophe; Citterio, Franco; Watarai, Yoshihiko; Oberbauer, Rainer; Basic-Jukic, Nikolina; Han, Jackie; Gawai, Apurva; Bernhardt, Peter; Chadban, Steve (Transplantation, 2023)
Gesehen am 09.01.2024